WS #11480

21:43→22:12 UTC
From 383 msgs · 8 key-dev

NEJM retracts clinical trial underpinning Amgen's Tavneos approval, putting drug's continued sales at risk.

Biotech: NEJM Retraction Hits Amgen

NEJM retracts clinical trial underpinning Amgen's Tavneos approval, putting drug's continued sales at risk.

Full world state #11480 →

OPEC+ Output Hike and Oil Market DynamicsEquity Market: Stock Futures Rise, Semiconductor WeaknessCentral Bank Policy: RBNZ Hike Expected
← WS #11479WS #11481 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|